Risk of Oxygen During Cardiac Surgery Trial

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 213 participants.

Also called NCT02361944

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 213 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02361944
Other papers using this trial's data
  • Effects of Oxygen on Perioperative Vascular Function: A Randomized Clinical Trial Journal of the American Heart Association, 2025-08-05 DOI, PubMed 40673571, PMC12450019 In the PMC Open Access subset under CC BY-NC-ND.
  • Intraoperative Oxygen Treatment, Oxidative Stress, and Organ Injury Following Cardiac Surgery: A Randomized Clinical Trial JAMA surgery, 2024-10-01 DOI, PubMed 39110454, PMC11307166 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02361944. Randomized; double masking; primary purpose prevention. Start 2016-04-05 (actual); primary completion 2020-10-08 (actual). Results posted on 2023-08-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Risk of Oxygen During Cardiac Surgery Trial
Acronym
ROCS
Condition
Cardiac Surgery
Intervention (Drug)
Oxygen - normoxia
Intervention (Drug)
Oxygen - hyperoxia
Lead sponsor
Vanderbilt University (class: other)
Collaborator
National Institute of General Medical Sciences (NIGMS) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct02361944
Content hash
8721e4ceddccd3c20dd8a55302187e05f012dec98f50c3b21cd2d20fdb98771c